Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy ; volume:24 ; number:1 ; day:6 ; month:8 ; year:2024 ; pages:1-14 ; date:12.2024
Clinical and experimental medicine ; 24, Heft 1 (6.8.2024), 1-14, 12.2024
- Urheber
-
Rehman, Maheen
Qaiser, Ariba
Khan, Hassan Sardar
Manzoor, Sobia
Ashraf, Javed
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10238-024-01442-9
- URN
-
urn:nbn:de:101:1-2410262113442.136736164507
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rehman, Maheen
- Qaiser, Ariba
- Khan, Hassan Sardar
- Manzoor, Sobia
- Ashraf, Javed
- SpringerLink (Online service)
Ähnliche Objekte (12)
The role of MSCs and CAR-MSCs in cellular immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
New cell sources for CAR-based immunotherapy
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Armed T cells with CAR for cancer immunotherapy
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
Enhancing in-car prediction by Car2X communication
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
The role of MSCs and CAR-MSCs in cellular immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
New cell sources for CAR-based immunotherapy
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Armed T cells with CAR for cancer immunotherapy
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
Enhancing in-car prediction by Car2X communication
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
The role of MSCs and CAR-MSCs in cellular immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
New cell sources for CAR-based immunotherapy
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Armed T cells with CAR for cancer immunotherapy
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
Enhancing in-car prediction by Car2X communication
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T